No act with the title Federal Claims Collection Act of 1996, referred to in subsec. (c)(1)(C), has been enacted. However, Pub. L. 89–508,
Parts A and B, referred to in subsec. (e)(3)(A)(ii)(I), probably means parts A and B of subchapter XVIII of this chapter. This subchapter does not contain parts.
A prior section 1935 of act
2019—Subsec. (e)(1)(B). Pub. L. 116–94, § 202(b)(1), substituted “subject to paragraph (4), if the State” for “if the State”.
Subsec. (e)(4), (5). Pub. L. 116–94, § 202(b)(2), (3), added par. (4) and redesignated former par. (4) as (5).
2008—Subsec. (a). Pub. L. 110–275 amended heading to include reference to medicare cost-sharing and added par. (4).
2005—Subsec. (c)(3)(B)(ii)(II). Pub. L. 109–91 inserted “, including drugs described in subparagraph (K) of section 1396r–8(d)(2) of this title” after “section 1395w–102(e) of this title”.
2003—Subsec. (a). Pub. L. 108–173, § 103(d)(1)(A), inserted “subject to subsection (e)” after “section 1396b(a) of this title” in introductory provisions.
Subsec. (c). Pub. L. 108–173, § 103(b), added subsec. (c).
Subsec. (c)(1)(C). Pub. L. 108–173, § 103(d)(1)(B), which directed the amendment of subsec. (c)(1) by inserting “subject to subsection (e)” after “section 1396b(a)(1) of this title”, was executed by making the insertion after “section 1396b(a) of this title” in subpar. (C) to reflect the probable intent of Congress.
Subsec. (d). Pub. L. 108–173, § 103(c), added subsec. (d).
Subsec. (e). Pub. L. 108–173, § 103(d)(1)(C), added subsec. (e).
Amendment by Pub. L. 110–275 effective
Amendment by Pub. L. 109–91 applicable to drugs dispensed on or after